← Back to Clinical Trials
Recruiting NCT07325604

NCT07325604 Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07325604
Status Recruiting
Phase
Sponsor University of Aarhus
Condition Facial Palsy
Study Type INTERVENTIONAL
Enrollment 130 participants
Start Date 2026-02-27
Primary Completion 2030-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Neuromuscular electrical stimulation (NMES)Usual Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 130 participants in total. It began in 2026-02-27 with a primary completion date of 2030-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background Central facial palsy (CFP) is a common condition in stroke, with an estimated prevalence of 45%. CFP can lead to facial asymmetry, problems with mouth closure and food processing, bite marks on the cheek, social isolation, and reduced quality of life. CFP is seen as an important area of rehabilitation, and training is therefore often carried out to reduce the consequences of CFP. In a recent systematic review conducted by the principal investigator, the results showed that very few studies have been conducted that have investigated the effect of training for CFP, and there is currently no scientific evidence to support the effect of the various training interventions. Objective To investigate the effect of Neuromuscular electrical stimulation (NMES) on facial symmetry compared to usual practice, in participants with CFP as a result of stroke. Hypothesis: Participants who receive training with NMES together with usual training for facial paralysis have greater improvement in facial symmetry than participants who only receive usual training for facial paralysis. Trial design Randomized controlled trial (RCT) with a nested pilot trial. A pilot trial/RCT will be conducted in order to power calculation in an RCT. The protocol for the pilot trial and RCT will be the same, and participants from the pilot trial and their outcome data are thus expected to be included in the RCT.

Eligibility Criteria

Inclusion Criteria: * Central facial palsy * First time stroke * \>=18 years * Able to provide written consent Exclusion Criteria: * Not able to cooperate for mimical exercises * Contraindications for NMES * Admitted for three weeks assessment stay at the hospital

Contact & Investigator

Central Contact

Jesper Fabricius, PhD

✉ jesperjm@hotmail.com

📞 +4578419051

Principal Investigator

Jesper Fabricius, PhD

PRINCIPAL INVESTIGATOR

Hammel Neurorehabilitation Centre and University Research Clinic & Department of clinical medicine, Aarhus University

Frequently Asked Questions

Who can join the NCT07325604 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Facial Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07325604 currently recruiting?

Yes, NCT07325604 is actively recruiting participants. Contact the research team at jesperjm@hotmail.com for enrollment information.

Where is the NCT07325604 trial being conducted?

This trial is being conducted at Hammel, Denmark.

Who is sponsoring the NCT07325604 clinical trial?

NCT07325604 is sponsored by University of Aarhus. The principal investigator is Jesper Fabricius, PhD at Hammel Neurorehabilitation Centre and University Research Clinic & Department of clinical medicine, Aarhus University. The trial plans to enroll 130 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology